| Pharmaceutical active ingredients: |
| Cilastatin SodiumImipenem Monohydrate |
| Available forms, composition and doses of Lemibet I.V.: |
| Injectable; Injection; Cilastatin Sodium 500 mg; Imipenem Monohydrate 500 mg |
| Lemibet I.V. medical category: |
| Human:Beta-LactamsCarbapenems |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01DH51 - Imipenem and enzyme Inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Teva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lemesil | Nimesulide | Anfarm Ellas |
| Lemetic | Bromopride | Ferrer Farma |
| Lemgrip | Acetaminophen | Reckitt Benckiser |
| Lemibet | Cilastatin Sodium; Imipenem Monohydrate | Teva |
| Lemibet I.M. | Cilastatin Sodium; Imipenem Monohydrate | Teva |
| Lemicin | Amikacin | Admac Pharma |
| Lemil | Bismuth Salicylate; Bismuth Subgallate; Boric Acid | Federacion Argentina de Cooperativas Farmaceuticas |
| Leminee 23 | Alkyl Dimethyl Ethylbenzyl Ammonium Chloride; Benzalkonium Chloride | Avmor; H & A Caretaker Supplies 1988; Produits Capital |
| Leminee 23 Cleaner / Disinfectant | Alkyl Dimethyl Ethylbenzyl Ammonium Chloride; Benzalkonium Chloride | Avmor; Star Industries 1997 |
| Leminee 64 | Benzalkonium Chloride; Didecyl Dimethyl Ammonium Chloride; Dioctyl Dimethyl Ammonium Chloride; Octyl Decyl Dimethyl Ammonium Chloride | Avmor |